Global Liposomal Amphoteracin B Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Liposomal Amphoteracin B Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 25mg
1.2.3 50mg
1.3 Market Segment by Application
1.3.1 Global Liposomal Amphoteracin B Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Liposomal Amphoteracin B Market Size (2017-2028)
2.1.1 Global Liposomal Amphoteracin B Revenue (2017-2028)
2.1.2 Global Liposomal Amphoteracin B Sales (2017-2028)
2.2 Global Liposomal Amphoteracin B Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Liposomal Amphoteracin B Sales by Regions (2017-2022)
2.2.2 Global Liposomal Amphoteracin B Revenue by Regions (2017-2022)
2.3 Global Liposomal Amphoteracin B Market Size Forecast by Region
2.3.1 Global Liposomal Amphoteracin B Sales Forecast by Region (2023-2028)
2.3.2 Global Liposomal Amphoteracin B Revenue Forecast by Region (2023-2028)
2.4 Global Top Liposomal Amphoteracin B Regions (Countries) Ranking by Market Size
2.5 Liposomal Amphoteracin B Market Dynamics
2.5.1 Liposomal Amphoteracin B Market Trends
2.5.2 Liposomal Amphoteracin B Market Drivers
2.5.3 Liposomal Amphoteracin B Market Challenges
2.5.4 Liposomal Amphoteracin B Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Liposomal Amphoteracin B Manufacturers by Sales (2017-2022)
3.1.1 Global Liposomal Amphoteracin B Sales by Manufacturers (2017-2022)
3.1.2 Global Liposomal Amphoteracin B Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Liposomal Amphoteracin B Sales in 2021
3.2 Global Top Manufacturers Liposomal Amphoteracin B by Revenue
3.2.1 Global Liposomal Amphoteracin B Revenue by Manufacturers (2017-2022)
3.2.2 Top Liposomal Amphoteracin B Manufacturers Covered: Ranking by Revenue
3.2.3 Global Liposomal Amphoteracin B Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Liposomal Amphoteracin B Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomal Amphoteracin B as of 2021)
3.4 Global Liposomal Amphoteracin B Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Liposomal Amphoteracin B Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Liposomal Amphoteracin B Market
3.7 Key Manufacturers Liposomal Amphoteracin B Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Liposomal Amphoteracin B Market Size by Type
4.1 Global Liposomal Amphoteracin B Historic Market Review by Type (2017-2022)
4.1.1 Global Liposomal Amphoteracin B Sales Market Share by Type (2017-2022)
4.1.2 Global Liposomal Amphoteracin B Revenue Market Share by Type (2017-2022)
4.1.3 Liposomal Amphoteracin B Price by Type (2017-2022)
4.2 Global Liposomal Amphoteracin B Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Liposomal Amphoteracin B Sales Forecast by Type (2023-2028)
4.2.2 Global Liposomal Amphoteracin B Revenue Forecast by Type (2023-2028)
4.2.3 Liposomal Amphoteracin B Price Forecast by Type (2023-2028)
5 Global Liposomal Amphoteracin B Market Size by Application
5.1 Global Liposomal Amphoteracin B Historic Market Review by Application (2017-2022)
5.1.1 Global Liposomal Amphoteracin B Sales Market Share by Application (2017-2022)
5.1.2 Global Liposomal Amphoteracin B Revenue Market Share by Application (2017-2022)
5.1.3 Liposomal Amphoteracin B Price by Application (2017-2022)
5.2 Global Liposomal Amphoteracin B Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Liposomal Amphoteracin B Sales Forecast by Application (2023-2028)
5.2.2 Global Liposomal Amphoteracin B Revenue Forecast by Application (2023-2028)
5.2.3 Liposomal Amphoteracin B Price Forecast by Application (2023-2028)
6 North America
6.1 North America Liposomal Amphoteracin B Sales Breakdown by Company
6.1.1 North America Liposomal Amphoteracin B Sales by Company (2017-2022)
6.1.2 North America Liposomal Amphoteracin B Revenue by Company (2017-2022)
6.2 North America Liposomal Amphoteracin B Market Size by Type
6.2.1 North America Liposomal Amphoteracin B Sales by Type (2017-2028)
6.2.2 North America Liposomal Amphoteracin B Revenue by Type (2017-2028)
6.3 North America Liposomal Amphoteracin B Market Size by Application
6.3.1 North America Liposomal Amphoteracin B Sales by Application (2017-2028)
6.3.2 North America Liposomal Amphoteracin B Revenue by Application (2017-2028)
6.4 North America Liposomal Amphoteracin B Market Size by Country
6.4.1 North America Liposomal Amphoteracin B Sales by Country (2017-2028)
6.4.2 North America Liposomal Amphoteracin B Revenue by Country (2017-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Liposomal Amphoteracin B Sales Breakdown by Company
7.1.1 Europe Liposomal Amphoteracin B Sales by Company (2017-2022)
7.1.2 Europe Liposomal Amphoteracin B Revenue by Company (2017-2022)
7.2 Europe Liposomal Amphoteracin B Market Size by Type
7.2.1 Europe Liposomal Amphoteracin B Sales by Type (2017-2028)
7.2.2 Europe Liposomal Amphoteracin B Revenue by Type (2017-2028)
7.3 Europe Liposomal Amphoteracin B Market Size by Application
7.3.1 Europe Liposomal Amphoteracin B Sales by Application (2017-2028)
7.3.2 Europe Liposomal Amphoteracin B Revenue by Application (2017-2028)
7.4 Europe Liposomal Amphoteracin B Market Size by Country
7.4.1 Europe Liposomal Amphoteracin B Sales by Country (2017-2028)
7.4.2 Europe Liposomal Amphoteracin B Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Liposomal Amphoteracin B Sales Breakdown by Company
8.1.1 Asia Pacific Liposomal Amphoteracin B Sales by Company (2017-2022)
8.1.2 Asia Pacific Liposomal Amphoteracin B Revenue by Company (2017-2022)
8.2 Asia Pacific Liposomal Amphoteracin B Market Size by Type
8.2.1 Asia Pacific Liposomal Amphoteracin B Sales by Type (2017-2028)
8.2.2 Asia Pacific Liposomal Amphoteracin B Revenue by Type (2017-2028)
8.3 Asia Pacific Liposomal Amphoteracin B Market Size by Application
8.3.1 Asia Pacific Liposomal Amphoteracin B Sales by Application (2017-2028)
8.3.2 Asia Pacific Liposomal Amphoteracin B Revenue by Application (2017-2028)
8.4 Asia Pacific Liposomal Amphoteracin B Market Size by Region
8.4.1 Asia Pacific Liposomal Amphoteracin B Sales by Region
8.4.2 Asia Pacific Liposomal Amphoteracin B Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Liposomal Amphoteracin B Sales Breakdown by Company
9.1.1 Latin America Liposomal Amphoteracin B Sales by Company (2017-2022)
9.1.2 Latin America Liposomal Amphoteracin B Revenue by Company (2017-2022)
9.2 Latin America Liposomal Amphoteracin B Market Size by Type
9.2.1 Latin America Liposomal Amphoteracin B Sales by Type (2017-2028)
9.2.2 Latin America Liposomal Amphoteracin B Revenue by Type (2017-2028)
9.3 Latin America Liposomal Amphoteracin B Market Size by Application
9.3.1 Latin America Liposomal Amphoteracin B Sales by Application (2017-2028)
9.3.2 Latin America Liposomal Amphoteracin B Revenue by Application (2017-2028)
9.4 Latin America Liposomal Amphoteracin B Market Size by Country
9.4.1 Latin America Liposomal Amphoteracin B Sales by Country (2017-2028)
9.4.2 Latin America Liposomal Amphoteracin B Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Liposomal Amphoteracin B Sales Breakdown by Company
10.1.1 Middle East and Africa Liposomal Amphoteracin B Sales by Company (2017-2022)
10.1.2 Middle East and Africa Liposomal Amphoteracin B Revenue by Company (2017-2022)
10.2 Middle East and Africa Liposomal Amphoteracin B Market Size by Type
10.2.1 Middle East and Africa Liposomal Amphoteracin B Sales by Type (2017-2028)
10.2.2 Middle East and Africa Liposomal Amphoteracin B Revenue by Type (2017-2028)
10.3 Middle East and Africa Liposomal Amphoteracin B Market Size by Application
10.3.1 Middle East and Africa Liposomal Amphoteracin B Sales by Application (2017-2028)
10.3.2 Middle East and Africa Liposomal Amphoteracin B Revenue by Application (2017-2028)
10.4 Middle East and Africa Liposomal Amphoteracin B Market Size by Country
10.4.1 Middle East and Africa Liposomal Amphoteracin B Sales by Country (2017-2028)
10.4.2 Middle East and Africa Liposomal Amphoteracin B Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Corporation Information
11.1.2 Gilead Sciences Overview
11.1.3 Gilead Sciences Liposomal Amphoteracin B Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Gilead Sciences Liposomal Amphoteracin B Products and Services
11.1.5 Gilead Sciences Liposomal Amphoteracin B SWOT Analysis
11.1.6 Gilead Sciences Recent Developments
11.2 Cipla
11.2.1 Cipla Corporation Information
11.2.2 Cipla Overview
11.2.3 Cipla Liposomal Amphoteracin B Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Cipla Liposomal Amphoteracin B Products and Services
11.2.5 Cipla Liposomal Amphoteracin B SWOT Analysis
11.2.6 Cipla Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Liposomal Amphoteracin B Value Chain Analysis
12.2 Liposomal Amphoteracin B Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Liposomal Amphoteracin B Production Mode & Process
12.4 Liposomal Amphoteracin B Sales and Marketing
12.4.1 Liposomal Amphoteracin B Sales Channels
12.4.2 Liposomal Amphoteracin B Distributors
12.5 Liposomal Amphoteracin B Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of TablesTable 1. Global Liposomal Amphoteracin B Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 25mg
Table 3. Major Manufacturers of 50mg
Table 4. Global Liposomal Amphoteracin B Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Liposomal Amphoteracin B Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Liposomal Amphoteracin B Sales by Region (2017-2022) & (K Units)
Table 7. Global Liposomal Amphoteracin B Sales Market Share by Region (2017-2022)
Table 8. Global Liposomal Amphoteracin B Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Liposomal Amphoteracin B Revenue Market Share by Region (2017-2022)
Table 10. Global Liposomal Amphoteracin B Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Liposomal Amphoteracin B Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Liposomal Amphoteracin B Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Liposomal Amphoteracin B Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Liposomal Amphoteracin B Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Liposomal Amphoteracin B Market Trends
Table 16. Liposomal Amphoteracin B Market Drivers
Table 17. Liposomal Amphoteracin B Market Challenges
Table 18. Liposomal Amphoteracin B Market Restraints
Table 19. Global Liposomal Amphoteracin B Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Liposomal Amphoteracin B Sales Share by Manufacturers (2017-2022)
Table 21. Global Liposomal Amphoteracin B Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Liposomal Amphoteracin B Manufacturers by Revenue (US$ Million) in 2021
Table 23. Liposomal Amphoteracin B Revenue Share by Manufacturers (2017-2022)
Table 24. Global Liposomal Amphoteracin B Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomal Amphoteracin B as of 2021)
Table 26. Key Manufacturers Liposomal Amphoteracin B Average Selling Price (ASP) & (2017-2022) & (US$/Unit)
Table 27. Key Manufacturers Liposomal Amphoteracin B Plants/Factories Distribution
Table 28. Key Manufacturers Liposomal Amphoteracin B Area Served
Table 29. Date of Key Manufacturers Enter into Liposomal Amphoteracin B Market
Table 30. Key Manufacturers Liposomal Amphoteracin B Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Liposomal Amphoteracin B Sales (K Units) by Type (2017-2022)
Table 33. Global Liposomal Amphoteracin B Sales Share by Type (2017-2022)
Table 34. Global Liposomal Amphoteracin B Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Liposomal Amphoteracin B Price (K Units) by Type (2017-2022)
Table 36. Global Liposomal Amphoteracin B Sales (K Units) by Type (2023-2028)
Table 37. Global Liposomal Amphoteracin B Sales Share by Type (2023-2028)
Table 38. Global Liposomal Amphoteracin B Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Liposomal Amphoteracin B Revenue Share by Type (2023-2028)
Table 40. Global Liposomal Amphoteracin B Price (K Units) by Type (2023-2028)
Table 41. Global Liposomal Amphoteracin B Sales (K Units) by Application (2017-2022)
Table 42. Global Liposomal Amphoteracin B Sales Share by Application (2017-2022)
Table 43. Global Liposomal Amphoteracin B Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Liposomal Amphoteracin B Price (K Units) by Application (2017-2022)
Table 45. Global Liposomal Amphoteracin B Sales (K Units) by Application (2023-2028)
Table 46. Global Liposomal Amphoteracin B Sales Share by Application (2023-2028)
Table 47. Global Liposomal Amphoteracin B Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Liposomal Amphoteracin B Revenue Share by Application (2023-2028)
Table 49. Global Liposomal Amphoteracin B Price (K Units) by Application (2023-2028)
Table 50. North America Liposomal Amphoteracin B Sales by Company (2017-2022) & (K Units)
Table 51. North America Liposomal Amphoteracin B Sales Market Share by Company (2017-2022)
Table 52. North America Liposomal Amphoteracin B Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Liposomal Amphoteracin B Revenue Market Share by Company (2017-2022)
Table 54. North America Liposomal Amphoteracin B Sales by Type (2017-2022) & (K Units)
Table 55. North America Liposomal Amphoteracin B Sales by Type (2023-2028) & (K Units)
Table 56. North America Liposomal Amphoteracin B Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Liposomal Amphoteracin B Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Liposomal Amphoteracin B Sales by Application (2017-2022) & (K Units)
Table 59. North America Liposomal Amphoteracin B Sales by Application (2023-2028) & (K Units)
Table 60. North America Liposomal Amphoteracin B Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Liposomal Amphoteracin B Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Liposomal Amphoteracin B Sales by Country (2017-2022) & (K Units)
Table 63. North America Liposomal Amphoteracin B Sales by Country (2023-2028) & (K Units)
Table 64. North America Liposomal Amphoteracin B Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Liposomal Amphoteracin B Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Liposomal Amphoteracin B Sales by Company (2017-2022) & (K Units)
Table 67. Europe Liposomal Amphoteracin B Sales Market Share by Company (2017-2022)
Table 68. Europe Liposomal Amphoteracin B Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Liposomal Amphoteracin B Revenue Market Share by Company (2017-2022)
Table 70. Europe Liposomal Amphoteracin B Sales by Type (2017-2022) & (K Units)
Table 71. Europe Liposomal Amphoteracin B Sales by Type (2023-2028) & (K Units)
Table 72. Europe Liposomal Amphoteracin B Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Liposomal Amphoteracin B Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Liposomal Amphoteracin B Sales by Application (2017-2022) & (K Units)
Table 75. Europe Liposomal Amphoteracin B Sales by Application (2023-2028) & (K Units)
Table 76. Europe Liposomal Amphoteracin B Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Liposomal Amphoteracin B Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Liposomal Amphoteracin B Sales by Country (2017-2022) & (K Units)
Table 79. Europe Liposomal Amphoteracin B Sales by Country (2023-2028) & (K Units)
Table 80. Europe Liposomal Amphoteracin B Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Liposomal Amphoteracin B Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Liposomal Amphoteracin B Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Liposomal Amphoteracin B Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Liposomal Amphoteracin B Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Liposomal Amphoteracin B Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Liposomal Amphoteracin B Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Liposomal Amphoteracin B Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Liposomal Amphoteracin B Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Liposomal Amphoteracin B Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Liposomal Amphoteracin B Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Liposomal Amphoteracin B Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Liposomal Amphoteracin B Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Liposomal Amphoteracin B Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Liposomal Amphoteracin B Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Liposomal Amphoteracin B Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Liposomal Amphoteracin B Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Liposomal Amphoteracin B Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Liposomal Amphoteracin B Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Liposomal Amphoteracin B Sales Market Share by Company (2017-2022)
Table 100. Latin America Liposomal Amphoteracin B Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Liposomal Amphoteracin B Revenue Market Share by Company (2017-2022)
Table 102. Latin America Liposomal Amphoteracin B Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Liposomal Amphoteracin B Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Liposomal Amphoteracin B Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Liposomal Amphoteracin B Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Liposomal Amphoteracin B Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Liposomal Amphoteracin B Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Liposomal Amphoteracin B Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Liposomal Amphoteracin B Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Liposomal Amphoteracin B Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Liposomal Amphoteracin B Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Liposomal Amphoteracin B Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Liposomal Amphoteracin B Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Liposomal Amphoteracin B Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Liposomal Amphoteracin B Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Liposomal Amphoteracin B Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Liposomal Amphoteracin B Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Liposomal Amphoteracin B Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Liposomal Amphoteracin B Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Liposomal Amphoteracin B Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Liposomal Amphoteracin B Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Liposomal Amphoteracin B Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Liposomal Amphoteracin B Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Liposomal Amphoteracin B Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Liposomal Amphoteracin B Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Liposomal Amphoteracin B Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Liposomal Amphoteracin B Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Liposomal Amphoteracin B Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Liposomal Amphoteracin B Revenue by Country (2023-2028) & (US$ Million)
Table 130. Gilead Sciences Corporation Information
Table 131. Gilead Sciences Description and Overview
Table 132. Gilead Sciences Liposomal Amphoteracin B Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 133. Gilead Sciences Liposomal Amphoteracin B Product and Services
Table 134. Gilead Sciences Liposomal Amphoteracin B SWOT Analysis
Table 135. Gilead Sciences Recent Developments
Table 136. Cipla Corporation Information
Table 137. Cipla Description and Overview
Table 138. Cipla Liposomal Amphoteracin B Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 139. Cipla Liposomal Amphoteracin B Product and Services
Table 140. Cipla Liposomal Amphoteracin B SWOT Analysis
Table 141. Cipla Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Liposomal Amphoteracin B Distributors List
Table 145. Liposomal Amphoteracin B Customers List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of FiguresFigure 1. Liposomal Amphoteracin B Product Picture
Figure 2. Global Liposomal Amphoteracin B Sales Market Share by Type in 2021 & 2028
Figure 3. 25mg Product Picture
Figure 4. 50mg Product Picture
Figure 5. Global Liposomal Amphoteracin B Sales Market Share by Application in 2021 & 2028
Figure 6. Hospital Use Case
Figure 7. Pharmacy Use Case
Figure 8. Liposomal Amphoteracin B Report Years Considered
Figure 9. Global Liposomal Amphoteracin B Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Liposomal Amphoteracin B Market Size 2017-2028 (US$ Million)
Figure 11. Global Liposomal Amphoteracin B Sales (2017-2022) & (K Units)
Figure 12. Global Liposomal Amphoteracin B Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Liposomal Amphoteracin B Sales Market Share by Region (2017-2022)
Figure 14. Global Liposomal Amphoteracin B Sales Market Share by Region in 2021
Figure 15. Global Liposomal Amphoteracin B Revenue Market Share by Region in 2017 VS 2021
Figure 16. Global Liposomal Amphoteracin B Sales Share by Manufacturers in 2021
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Liposomal Amphoteracin B Sales in 2021
Figure 18. Liposomal Amphoteracin B Revenue Share by Manufacturers in 2021
Figure 19. Liposomal Amphoteracin B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Liposomal Amphoteracin B Revenue Share by Type (2017-2022)
Figure 21. Global Liposomal Amphoteracin B Revenue Growth Rate by Type in 2017 & 2021
Figure 22. Global Liposomal Amphoteracin B Revenue Share by Application (2017-2022)
Figure 23. Global Liposomal Amphoteracin B Revenue Growth Rate by Application in 2017 & 2021
Figure 24. North America Liposomal Amphoteracin B Sales Market Share by Type (2017-2028)
Figure 25. North America Liposomal Amphoteracin B Revenue Market Share by Type (2017-2028)
Figure 26. North America Liposomal Amphoteracin B Sales Market Share by Application (2017-2028)
Figure 27. North America Liposomal Amphoteracin B Revenue Market Share by Application (2017-2028)
Figure 28. North America Liposomal Amphoteracin B Sales Share by Country (2017-2028)
Figure 29. North America Liposomal Amphoteracin B Revenue Share by Country (2017-2028)
Figure 30. United States Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 31. Canada Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 32. Europe Liposomal Amphoteracin B Sales Market Share by Type (2017-2028)
Figure 33. Europe Liposomal Amphoteracin B Revenue Market Share by Type (2017-2028)
Figure 34. Europe Liposomal Amphoteracin B Sales Market Share by Application (2017-2028)
Figure 35. Europe Liposomal Amphoteracin B Revenue Market Share by Application (2017-2028)
Figure 36. Europe Liposomal Amphoteracin B Sales Share by Country (2017-2028)
Figure 37. Europe Liposomal Amphoteracin B Revenue Share by Country (2017-2028)
Figure 38. Germany Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 39. France Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 40. U.K. Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 41. Italy Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 42. Russia Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 43. Asia Pacific Liposomal Amphoteracin B Sales Market Share by Type (2017-2028)
Figure 44. Asia Pacific Liposomal Amphoteracin B Revenue Market Share by Type (2017-2028)
Figure 45. Asia Pacific Liposomal Amphoteracin B Sales Market Share by Application (2017-2028)
Figure 46. Asia Pacific Liposomal Amphoteracin B Revenue Market Share by Application (2017-2028)
Figure 47. Asia Pacific Liposomal Amphoteracin B Sales Share by Region (2017-2028)
Figure 48. Asia Pacific Liposomal Amphoteracin B Revenue Share by Region (2017-2028)
Figure 49. China Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 50. Japan Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 51. South Korea Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 52. India Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 53. Australia Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 54. China Taiwan Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 55. Indonesia Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 56. Thailand Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 57. Malaysia Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 58. Latin America Liposomal Amphoteracin B Sales Market Share by Type (2017-2028)
Figure 59. Latin America Liposomal Amphoteracin B Revenue Market Share by Type (2017-2028)
Figure 60. Latin America Liposomal Amphoteracin B Sales Market Share by Application (2017-2028)
Figure 61. Latin America Liposomal Amphoteracin B Revenue Market Share by Application (2017-2028)
Figure 62. Latin America Liposomal Amphoteracin B Sales Share by Country (2017-2028)
Figure 63. Latin America Liposomal Amphoteracin B Revenue Share by Country (2017-2028)
Figure 64. Mexico Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 65. Brazil Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 66. Argentina Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 67. Middle East and Africa Liposomal Amphoteracin B Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Liposomal Amphoteracin B Revenue Market Share by Type (2017-2028)
Figure 69. Middle East and Africa Liposomal Amphoteracin B Sales Market Share by Application (2017-2028)
Figure 70. Middle East and Africa Liposomal Amphoteracin B Revenue Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Liposomal Amphoteracin B Sales Share by Country (2017-2028)
Figure 72. Middle East and Africa Liposomal Amphoteracin B Revenue Share by Country (2017-2028)
Figure 73. Turkey Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 74. Saudi Arabia Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 75. UAE Liposomal Amphoteracin B Revenue (2017-2028) & (US$ Million)
Figure 76. Liposomal Amphoteracin B Value Chain
Figure 77. Liposomal Amphoteracin B Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed